Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Total Assets 2010-2024 | MKKGY

Merck total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Merck total assets for the quarter ending June 30, 2024 were $53.710B, a 0.97% increase year-over-year.
  • Merck total assets for 2023 were $52.486B, a 2.66% increase from 2022.
  • Merck total assets for 2022 were $51.127B, a 4.73% decline from 2021.
  • Merck total assets for 2021 were $53.668B, a 12.41% increase from 2020.
  
Merck Annual Total Assets
(Millions of US $)
2023 $52,486
2022 $51,127
2021 $53,668
2020 $47,744
2019 $49,068
2018 $43,565
2017 $40,262
2016 $42,329
2015 $42,177
2014 $34,575
2013 $27,653
2012 $27,835
2011 $30,813
2010 $0
2009 $0
Merck Quarterly Total Assets
(Millions of US $)
2024-06-30 $53,710
2024-03-31 $53,746
2023-12-31 $52,486
2023-09-30 $54,318
2023-06-30 $53,192
2023-03-31 $52,207
2022-12-31 $51,127
2022-09-30 $51,300
2022-06-30 $51,845
2022-03-31 $51,885
2021-12-31 $53,668
2021-09-30 $51,691
2021-06-30 $51,985
2021-03-31 $52,915
2020-12-31 $47,744
2020-09-30 $50,537
2020-06-30 $48,252
2020-03-31 $49,360
2019-12-31 $49,068
2019-09-30 $46,779
2019-06-30 $44,474
2019-03-31 $43,975
2018-12-31 $43,565
2018-09-30 $41,555
2018-06-30 $42,728
2018-03-31 $43,237
2017-12-31 $40,262
2017-09-30 $42,111
2017-06-30 $40,448
2017-03-31 $40,871
2016-12-31 $42,329
2016-09-30 $41,004
2016-06-30 $41,825
2016-03-31 $41,010
2015-12-31 $42,177
2015-09-30 $35,900
2015-06-30 $32,969
2015-03-31 $34,721
2014-12-31 $34,575
2014-09-30 $30,149
2014-06-30 $29,461
2014-03-31 $28,792
2013-12-31 $27,653
2013-09-30 $28,251
2013-06-30 $28,456
2013-03-31 $28,999
2012-12-31 $27,835
2012-09-30 $27,864
2012-06-30 $28,136
2012-03-31 $0
2011-12-31 $30,813
2011-09-30 $0
2011-06-30 $31,500
2011-03-31 $0
2010-12-31 $0
2010-09-30 $29,683
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.192B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.770B 30.70
Takeda Pharmaceutical (TAK) Japan $44.101B 9.18
Astellas Pharma (ALPMY) Japan $19.074B 17.57
Sandoz Group AG (SDZNY) Switzerland $18.921B 0.00
United Therapeutics (UTHR) United States $16.524B 16.25
Summit Therapeutics (SMMT) United States $13.635B 0.00
Neurocrine Biosciences (NBIX) United States $12.746B 33.75
Shionogi (SGIOY) Japan $11.978B 12.00
Catalent (CTLT) United States $11.150B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.948B 0.00
Orion OYJ (ORINY) Finland $6.605B 18.57
Corcept Therapeutics (CORT) United States $6.204B 46.99
Ionis Pharmaceuticals (IONS) United States $5.700B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.322B 0.00
PTC Therapeutics (PTCT) United States $4.016B 0.00
Dyne Therapeutics (DYN) United States $2.980B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.687B 12.18
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.655B 15.87
Centessa Pharmaceuticals (CNTA) United Kingdom $2.235B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.173B 0.00
Soleno Therapeutics (SLNO) United States $2.156B 0.00
Xencor (XNCR) United States $1.878B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.814B 0.00
Evotec AG (EVO) Germany $1.673B 0.00
Indivior (INDV) United States $1.548B 6.31
Guardian Pharmacy Services (GRDN) United States $1.537B 0.00
Ocular Therapeutix (OCUL) United States $1.536B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.529B 0.00
Harrow (HROW) United States $1.491B 0.00
Ardelyx (ARDX) United States $1.312B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.303B 0.00
ARS Pharmaceuticals (SPRY) United States $1.295B 0.00
Enliven Therapeutics (ELVN) United States $1.194B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.117B 0.00
Collegium Pharmaceutical (COLL) United States $1.010B 5.52
Bioventus (BVS) United States $0.997B 31.49
Cronos Group (CRON) Canada $0.791B 0.00
Relay Therapeutics (RLAY) United States $0.782B 0.00
USANA Health Sciences (USNA) United States $0.763B 14.14
Oruka Therapeutics (ORKA) United States $0.734B 0.00
Tourmaline Bio (TRML) United States $0.658B 0.00
Elite Pharmaceuticals (ELTP) United States $0.646B 0.00
Altimmune (ALT) United States $0.629B 0.00
ProKidney (PROK) United States $0.621B 0.00
Esperion Therapeutics (ESPR) United States $0.611B 0.00
Verve Therapeutics (VERV) United States $0.606B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.579B 0.00
Savara (SVRA) United States $0.567B 0.00
OmniAb (OABI) United States $0.562B 0.00
Zevra Therapeutics (ZVRA) United States $0.517B 0.00
Organogenesis (ORGO) United States $0.512B 0.00
Siga Technologies (SIGA) United States $0.511B 5.96
Xeris Biopharma Holdings (XERS) United States $0.504B 0.00
Korro Bio (KRRO) United States $0.501B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.476B 193.21
Akebia Therapeutics (AKBA) United States $0.465B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.464B 0.00
KalVista Pharmaceuticals (KALV) United States $0.444B 0.00
Aquestive Therapeutics (AQST) United States $0.439B 0.00
Larimar Therapeutics (LRMR) United States $0.396B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.380B 0.00
Sage Therapeutics (SAGE) United States $0.354B 0.00
4D Molecular Therapeutics (FDMT) United States $0.351B 0.00
Avita Medical (RCEL) United States $0.341B 0.00
Nature's Sunshine Products (NATR) United States $0.310B 18.42
Lyell Immunopharma (LYEL) United States $0.292B 0.00
Aldeyra Therapeutics (ALDX) United States $0.287B 0.00
Aclaris Therapeutics (ACRS) United States $0.283B 0.00
Lexeo Therapeutics (LXEO) United States $0.278B 0.00
Silence Therapeutics (SLN) United Kingdom $0.245B 0.00
Acrivon Therapeutics (ACRV) United States $0.232B 0.00
Nektar Therapeutics (NKTR) United States $0.218B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.217B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
MediWound (MDWD) Israel $0.195B 0.00
Heron Therapeutics (HRTX) United States $0.186B 0.00
Inhibikase Therapeutics (IKT) United States $0.185B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.182B 0.00
Galectin Therapeutics (GALT) United States $0.176B 0.00
Cassava Sciences (SAVA) United States $0.166B 0.00
Achieve Life Sciences (ACHV) Canada $0.151B 0.00
Nanobiotix S.A (NBTX) France $0.148B 0.00
Century Therapeutics (IPSC) United States $0.143B 0.00
CytoDyn (CYDY) United States $0.143B 0.00
VAXART, INC (VXRT) United States $0.135B 0.00
Cardiol Therapeutics (CRDL) Canada $0.128B 0.00
Telomir Pharmaceuticals (TELO) United States $0.126B 0.00
Fractyl Health (GUTS) United States $0.125B 0.00
Journey Medical (DERM) United States $0.122B 0.00
Pyxis Oncology (PYXS) United States $0.119B 0.00
Context Therapeutics (CNTX) United States $0.117B 0.00
Regulus Therapeutics (RGLS) United States $0.107B 0.00
Karyopharm Therapeutics (KPTI) United States $0.103B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Avalo Therapeutics (AVTX) United States $0.102B 0.00
Inotiv (NOTV) United States $0.101B 0.00
Relmada Therapeutics (RLMD) United States $0.099B 0.00
Assertio Holdings (ASRT) United States $0.098B 25.62
Arch Biopartners (ACHFF) Canada $0.090B 0.00
PMV Pharmaceuticals (PMVP) United States $0.087B 0.00
Vivani Medical (VANI) United States $0.086B 0.00
OptiNose (OPTN) United States $0.081B 0.00
Metagenomi (MGX) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
ElectroCore (ECOR) United States $0.074B 0.00
Mural Oncology (MURA) Ireland $0.071B 0.00
Scienture Holdings (SCNX) United States $0.066B 0.00
Iterum Therapeutics (ITRM) Ireland $0.066B 0.00
AlloVir (ALVR) United States $0.061B 0.00
CASI Pharmaceuticals (CASI) China $0.061B 0.00
Champions Oncology (CSBR) United States $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
BioVie (BIVI) United States $0.055B 0.00
Protara Therapeutics (TARA) United States $0.052B 0.00
Nutriband (NTRB) United States $0.051B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
VYNE Therapeutics (VYNE) United States $0.042B 0.00
FibroGen (FGEN) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
Surrozen (SRZN) United States $0.037B 0.00
Carisma Therapeutics (CARM) United States $0.035B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.032B 0.00
Incannex Healthcare (IXHL) Australia $0.030B 0.00
Natural Alternatives (NAII) United States $0.029B 0.00
DURECT (DRRX) United States $0.029B 0.00
CERo Therapeutics Holdings (CERO) United States $0.027B 0.00
BioLineRx (BLRX) Israel $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Lipocine (LPCN) United States $0.023B 0.00
GlycoMimetics (GLYC) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Cosmos Health (COSM) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
NRx Pharmaceuticals (NRXP) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Talphera (TLPH) United States $0.013B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.012B 0.00
Conduit Pharmaceuticals (CDT) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Oncternal Therapeutics (ONCT) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.12
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 39.31